Lv11
20 积分 2024-07-17 加入
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
4小时前
待确认
Extracellular targeted protein degradation: an emerging modality for drug discovery
1个月前
已完结
Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders
2个月前
已完结
Optimization of Peptide Drug Exposures for Pharmacological Efficacy: DMPK Considerations
3个月前
已完结
Metabolism and Excretion of Therapeutic Peptides: Current Industry Practices, Perspectives, and Recommendations
4个月前
已完结
DRUG-INDUCED LIVER INJURY: MECHANISMS, METHODS FOR PRE-CLINICAL ASSESSMENT, AND A MEDICINAL CHEMIST’S PERSPECTIVE
4个月前
已关闭
Variations in protein binding of drugs in plasma and serum
7个月前
已完结
Metabolism and Excretion of Therapeutic Peptides: Current Industry Practices, Perspectives, and Recommendations
7个月前
已完结
Species Comparison of Metabolism in Microsomes and Hepatocytes
11个月前
已关闭
皖公网安备34019202002308
